North America Muscle Stimulation Devices Market

North America Muscle Stimulation Devices Market Size (2023 to 2028):

The size of the North America Muscle Stimulation Devices Market was valued at USD 166.13 Million in 2023 and is poised to reach USD 217.34 Million by 2028, estimated to grow at a healthy rate of 5.52% from 2023 to 2028.

Y-O-Y growth in the incidence of head and spinal cord injuries in North American countries is primarily fuelling the market. Seventeen thousand seven hundred thirty spinal cord injury cases take place every year, and presently 249,000 and 363,000 are living with spinal cord injuries in the U.S. in 2019, according to the National Spinal Cord Injury Statistical Center at the University of Alabama at Birmingham. Factors like popularity in sports, initiatives are taken by the government in advancing healthcare costs, and escalating popularity in muscle stimulators with current trends in physiotherapists are to surge the region's market growth. According to the Centers for Diseases Control and Prevention, around 54.4 million U.S. adults were examined with arthritis in 2017, and the count is expected to rise to a 78million by 2040. The expected growth of arthritis is projected to bolster market growth in the region. Over 125 million people are aged above 80 years or above, according to the World Health Organization (WHO).

Less awareness among the people related to the electrotherapy treatment modalities is restraining the growth. Moreover, the lack of experienced professionals and physiotherapists in counseling the patients is declining the market demand.

This research report on the North America Muscle Stimulation Devices Market has been segmented and sub-segmented into the following categories:

By Product Type:

• Burst mode alternating current (BMAC)
• Interferential (IF)
• Transcutaneous electrical nerve stimulator (TENS)
• Neuromuscular electric stimulation (NMES)

By Application:

• Musculoskeletal disorder management
• Pain management
• Neurological
• Movement disorder management

By End User:

• Physiotherapy clinics
• Homecare
• Hospitals
• Sports clinics

By Country:

• US
• Canada
• Rest of North America

Regional Analysis:

North America is expected to hold a dominant position in the muscle stimulation devices market, accounting for 50.0% in terms of value during the period. U.S. muscle stimulation devices market dominated the North American region because of acceptable reimbursement policies and growing healthcare expenses. Occupancy of improved and upgraded healthcare infrastructure and an expected increase of musculoskeletal disorders like low back pain and spinal injuries in this country are prominent factors for market enlargement. Growing demand for pain management therapies and innovations in technology are driving the growth in the market. Technology developments, different new kinds of muscle stimulators are in the queue for FDA approvals. According to the American Academy of Orthopedic Surgeons, more than 126.6 million Americans have suffered from musculoskeletal conditions in 2016.

Canada is projected to have rapid growth in the muscle stimulation devices market with a share in value and revenue. Increase in regular lifestyle-related issues and growing access to high-quality healthcare, increase in elder people population, an increasing number of athletes and fitness persons use these muscle stimulation devices like Electrical muscle stimulation (EMS), TENS and galvanic as these are used in home care settings and gyms in escalating the market.

Promising Companies dominating the North America Muscle Stimulation Devices Market Profiled in the Report are DJO Global, Inc., Zynex, Inc., NeuroMetrix, Inc., RS Medical, Inc., and Omron Corp.